| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/14/2008 | US20080038270 Antibody Specific For A Chondroitin Sulphate Epitope |
| 02/14/2008 | US20080038268 Streptococcus Pyogenes Antigens |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038260 specifically bind to monocyte-derived dendritic cells (MDDC); immunostimulants; downmodulating transplant rejection; cancer |
| 02/14/2008 | US20080038257 Hepatocyte growth factor (hgf) binding proteins |
| 02/14/2008 | US20080038255 Splice Variant of Unc5h2 |
| 02/14/2008 | US20080038232 Production of high mannose proteins in plant culture |
| 02/14/2008 | CA2694289A1 Polymyxin derivatives and uses thereof |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2659337A1 Combination therapy |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1887014A1 Human toll homologues |
| 02/13/2008 | EP1885868A2 Production of enzymes |
| 02/13/2008 | EP1885867A2 Novel methods |
| 02/13/2008 | EP1885847A2 Scalable fermentation process |
| 02/13/2008 | EP1885843A2 Peptide composition for growing and/or culturing micro-organisms and/or cells |
| 02/13/2008 | EP1885771A2 Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1885753A1 Production of recombinant il-18 binding protein |
| 02/13/2008 | EP1885396A2 Recombinant antibodies against cd55 and cd59 and uses thereof |
| 02/13/2008 | EP1517699B1 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 02/13/2008 | EP1451332B1 Production of eukaryotic proteins and nucleic acid molecules in c. elegans |
| 02/13/2008 | EP1292328B1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor |
| 02/13/2008 | EP1207200B1 High affinity choline transporter |
| 02/13/2008 | EP1005549B1 Prostate tumor polynucleotide and antigen compositions |
| 02/13/2008 | EP0946711B1 Improved expression vectors |
| 02/13/2008 | EP0837928B1 Recombinant poxvirus - cytomegalovirus compositions and uses |
| 02/13/2008 | EP0820509B1 Genes encoding lymphocyte interferon regulatory factor (lsirf) polypeptides |
| 02/13/2008 | EP0770138B1 Mycobacteria functional screening and/or expression vectors |
| 02/13/2008 | EP0764202B1 EXPRESSION PLASMIDS REGULATED BY AN osmB PROMOTER |
| 02/13/2008 | CN101124331A Site-directed modification of FVIII |
| 02/13/2008 | CN101124329A Genetically purified gellan gum |
| 02/13/2008 | CN101124237A Surface proteins of streptococcus pyogenes |
| 02/13/2008 | CN101123972A Methods for protein production |
| 02/13/2008 | CN101121749A Gamma-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/13/2008 | CN100368548C Linear expression carrier construction method need no clone |
| 02/13/2008 | CN100368544C Novel insecticidal toxins from i(xenorhabdus nematophilus) and nucleic acid sequences coding therefor |
| 02/13/2008 | CN100368540C Production method for recombinant cytoglobin and uses thereof |
| 02/12/2008 | US7329743 Antigenic peptides are useful as a vaccine |
| 02/12/2008 | US7329738 Assays for detection of Bacillus anthracis |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329728 Ligand activated transcriptional regulator proteins |
| 02/12/2008 | US7329646 recombinant methods; |
| 02/12/2008 | US7329544 Plant lesion formation suppressing gene, Sp17 and use thereof |
| 02/12/2008 | US7329530 Chimaeric phages |
| 02/12/2008 | US7329529 Ubiqutin proteases |
| 02/12/2008 | US7329527 Expression vector comprising nucleotide sequences coding serine protease for use as proteolytic agent in cleaning products |
| 02/12/2008 | US7329526 Serine proteases from-gram-positive microorganisms |
| 02/12/2008 | US7329525 Bacillus serine proteases for use as active agent in cleaning compounds and detergents |
| 02/12/2008 | US7329523 Microbiologic industry, such as breeding, L-serine production |
| 02/12/2008 | US7329522 Polyphosphate:AMP phosphotransferase |
| 02/12/2008 | US7329521 Transglutaminase-producing strain |
| 02/12/2008 | US7329520 Reacting the peptide or protein with an enzyme that is extracted from a plant of the genus Zingiber and exhibits defructosylation action |
| 02/12/2008 | US7329519 DNA encoding the cytochrome C, glucose sensor using an enzyme electrode, biosensors |
| 02/12/2008 | US7329518 Producing polycyclic pyridineethanol derivative by causing an enzyme or enzyme source to act on polycyclic acetylpyridine derivatives |
| 02/12/2008 | US7329513 High level constitutive production of anthrax protective antigen |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | US7329509 Culturing a host infected with recombinant baculovirus; co-expressing interacting protein, membrane-bound receptor protein in a budded baculovirus released from host |
| 02/12/2008 | US7329500 Moraxella (Branhamella) catarrhalis polypeptides and corresponding DNA fragments |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329498 Identifying a T-cell epitope in protein, modifying protein to neutralize T-cell epitope such that the modified protein induces less than or substantially equal the baseline proliferation of naive T-cells, and wherein the allergenicity of protein is reduced |
| 02/12/2008 | US7329406 Methods of treating psoriasis with αvβ3-specific antibodies |
| 02/12/2008 | CA2440025C Aminoketone asymmetric reductase and nucleic acid thereof |
| 02/12/2008 | CA2387018C Chemokine receptor |
| 02/12/2008 | CA2352609C Expression of alkaline phosphatase in yeast |
| 02/12/2008 | CA2268397C Magnetically activated cell sorting for production of proteins |
| 02/12/2008 | CA2258307C Method of producing heterologous short chain polypeptides by yeast with impaired yap3 protease |
| 02/12/2008 | CA2203246C Alk-7 (activin like kinase), a serine threonine kinase receptor |
| 02/12/2008 | CA2190802C A method of preparing and recovering proteins |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/07/2008 | WO2008016693A1 Method for determining the genetic basis for physiological changes in organisms |
| 02/07/2008 | WO2008016380A2 Installation of genomes or partial genomes into cells or cell-like systems |
| 02/07/2008 | WO2008015662A1 A method of producing recombinant biological products |
| 02/07/2008 | WO2007148345A3 A method of producing biologically active polypeptide having insulinotropic activity |
| 02/07/2008 | WO2007148092A3 In vitro protein expression process comprising cκ fusion molecules |
| 02/07/2008 | WO2007139767A3 Compositions and methods for the delivery of nitric oxide |
| 02/07/2008 | WO2007059360A3 Oral use of specific antibodies for intestinal health |
| 02/07/2008 | WO2007053655A3 Cell-free synthesis of membrane bound polypeptides |
| 02/07/2008 | WO2006091969A3 Predicting chemosensitivity to cytotoxic agents |
| 02/07/2008 | US20080034456 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 02/07/2008 | US20080034455 Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed |
| 02/07/2008 | US20080033148 Anti-il-tif antibodies and methods of using in inflammation |
| 02/07/2008 | US20080032947 Pka ligands and polynucleotides encoding pka ligands |
| 02/07/2008 | US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032930 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032927 Treatment of development-related disorders |
| 02/07/2008 | US20080032924 Antifungal Peptides |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032919 BMP-7 Variant Compositions, Methods and Uses |
| 02/07/2008 | US20080032896 Methods for identifying compounds that bind to a target |
| 02/07/2008 | US20080032378 have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or high-glucose syrup or a mixed syrup, and for liquifying a starch-comprising composition |
| 02/07/2008 | US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |
| 02/07/2008 | US20080032346 Method of increasing complementarity in a heteroduplex |
| 02/07/2008 | US20080032343 Recombinant Production of Heparin Binding Proteins |
| 02/07/2008 | US20080032342 Chimeric immunogens |
| 02/07/2008 | US20080032341 Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification, and transformant |
| 02/07/2008 | US20080032340 Peptide motifs for binding avidin or neutravidin |
| 02/07/2008 | US20080032339 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection |
| 02/07/2008 | US20080032338 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest |